| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 7.856 | 13.251 | 1.424 | 1.565 | 24.713 | 21.904 | 19.394 |
| Total Income - EUR | - | - | - | 7.856 | 13.251 | 1.424 | 2.373 | 24.713 | 22.268 | 19.394 |
| Total Expenses - EUR | - | - | - | 3.450 | 5.600 | 2.756 | 1.351 | 6.517 | 18.800 | 22.447 |
| Gross Profit/Loss - EUR | - | - | - | 4.407 | 7.651 | -1.332 | 1.022 | 18.195 | 3.468 | -3.053 |
| Net Profit/Loss - EUR | - | - | - | 4.174 | 7.253 | -1.374 | 951 | 17.948 | 3.279 | -3.565 |
| Employees | - | - | - | 1 | 0 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Dgc Premium Medica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 2.623 | 1.837 | 1.081 | 0 | 0 | 10.733 | 7.212 |
| Current Assets | - | - | - | 2.587 | 13.657 | 10.231 | 11.836 | 25.486 | 29.425 | 26.446 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 430 | 421 | 413 | 404 | 25.103 | 22.210 | 22.086 |
| Cash | - | - | - | 2.157 | 13.236 | 9.817 | 11.431 | 382 | 7.216 | 4.360 |
| Shareholders Funds | - | - | - | 4.217 | 11.388 | 9.798 | 10.542 | 22.439 | 25.650 | 21.942 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 993 | 4.107 | 1.515 | 1.294 | 3.046 | 14.509 | 11.716 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dgc Premium Medica S.r.l.